Author: Selina McKee

Shire purchase backed by Takeda shareholders

Takeda shareholders have backed the firm’s proposed £46 billion acquisition of Shire.

A third of doctors considering leaving clinical practice

A new report from the General Medical Council (GMC) has found that a third of doctors are considering leaving medical practice, meaning they would no longer be working in clinical facing roles.

UCB to invest £1bn into UK under life sciences sector deal

The government has published the second Life Sciences Sector Deal, detailing both public and private sector investments into the sector, including a £1 billion investment in UK research and development by UCB.

Norgine launches Shield’s Feraccru in the UK

Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.

First Alzheimer’s drug from Eisai/UCL alliance to enter clinical trials

The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.